Valbenazine Will Be Used to Reduce Tardive Dyskinesia Symptoms
Valbenazine (Ingrezza, in-GREH-zah) will be the first med approved to treat tardive dyskinesia.
Up to 30% of patients on long-term antipsychotics develop tardive dyskinesia...involuntary lip smacking, facial grimaces, etc.
It's usually associated with higher doses, longer durations, and higher-potency typical antipsychotics, such as haloperidol.
Get unlimited access through an Enterprise license
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Not sold to individuals